Pharmaceutical intellectual property laws need reform

November 07, 2011

Canada's pharmaceutical intellectual property laws need major reform to encourage and protect innovation in developing new drugs, states an analysis in CMAJ (Canadian Medical Association Journal).

The federal government supports drug innovation in several ways, including funding of basic research, and tax breaks for companies that conduct drug R&D in Canada. Patents, however, are the most significant and valuable form of support. Patents provide developers of new pharmaceuticals with exclusive rights to market drugs without competition from generic manufacturers. However, there are problems with the current approach.

"We argue that the system is broken," writes Dr. Paul Grootendorst, Leslie Dan Faculty of Pharmacy, University of Toronto, with coauthors. "The adjudication of patent validity (and hence the period of market exclusivity) is determined by extraordinarily costly and time-consuming litigation between generic and brand (i.e., innovator) drug companies."

They state the reasons for the dysfunction stem from complex rules and regulations that lead to legal ambiguity. The regulations also provide brand name and generic companies with the tools needed to contest the period of market exclusivity; brand firms use the regulations to delay generic entry while generic firms attempt to do the opposite. The outcome of this contest is an extraordinary amount of litigation between brand name and generic companies that has strained the federal courts and resulted in hundreds of millions of dollars in legal fees, costs that are passed on to drug plans and consumers.

The authors suggest that reform of the legal and regulatory framework for market exclusivity is needed. This could include replacing current regulations with a standard guaranteed fixed period for market exclusivity (perhaps 10 years); this would reduce litigation and improve investment certainty to brand firms. A second option would be to abolish the Patented Medicines (Notice of Compliance) regulations, which govern the introduction of generic versions of brand drugs still under patent, and to rely instead on the Patent Act.

"Other countries are facing the same challenges as Canada; none, however, have attempted fundamental reform of its laws on pharmaceutical intellectual property," conclude the authors. "It is time for Canada to show leadership."
-end-


Canadian Medical Association Journal

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.